CCL17 and classic Hodgkin lymphoma: Because pediatric and adult cHL differ partly with respect to histology, risk factors, clinical presentation, and staging at diagnosis and prognosis [16, 17, 18], further research is warranted to determine whether TARC is a diagnostic biomarker in pediatric cHL patients as well.